INTRODUCTIONThere are approximately 9000 new cases of aortic dissection in the United States each year. Uncomplicated type B aortic dissections are traditionally managed with medical therapy, controlling blood pressure and heart rate, with 30-day mortality rates between 4% and 10%. However, there is no consensus regarding the management of complicated (ie, presenting with malperfusion or refractory pain) type B dissections. Open surgical management of these patients carries an excessive mortality rate. Therefore, endovascular aortic fenestration and branch vessel stenting to relieve malperfusion was developed as an alternative to open surgical repair. While endovascular fenestration and stenting relieves malperfusion, it does not prevent late aneurysm degeneration of the aorta, which can occur in up to 30% of patients. Recently, the use of endovascular stent grafts to cover the primary and proximal entry tear has been examined, with the belief that this approach treats most cases of malperfusion and, in theory, prevents late aneurysm formation. The objective of this article is to examine the literature surrounding the endovascular management of type B aortic dissections, including fenestration and stenting, as well as stent graft placement.
BACKGROUND